The current IRWD market cap is 1.08B. The company's latest EPS is USD -6.4029 and P/E is -1.05.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 107.2M | 104.06M | 107.38M | 113.74M | 117.55M |
Operating Income | 68.36M | 60.1M | -1.08B | 40.02M | 37.59M |
Net Income | 48.87M | 45.71M | -1.06B | 15.32M | -1.09M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 431.94M | 389.52M | 413.8M | 410.6M | 442.74M |
Operating Income | 116.95M | 142.94M | 232.26M | 250.34M | -945.43M |
Net Income | 21.51M | 106.18M | 528.45M | 175.07M | -1B |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.1B | 1.16B | 603.22M | 524.06M | 471.07M |
Total Liabilities | 448.14M | 448.43M | 950M | 849.74M | 817.37M |
Total Equity | 652.38M | 706.85M | -346.78M | -325.68M | -346.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 402.75M | 559.24M | 1.13B | 1.1B | 471.07M |
Total Liabilities | 496M | 496.6M | 521.02M | 448.14M | 817.37M |
Total Equity | -93.25M | 62.64M | 605.91M | 652.38M | -346.3M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 273.76M | 80.17M | 115.13M | 147.59M | 183.43M |
Investing | -136k | -13k | -999.51M | -1.02B | -1.03B |
Financing | -237.55M | 3.98M | 403.05M | 328.06M | 277.16M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 10.73M | 168.84M | 261.9M | 273.76M | 183.43M |
Investing | -11.14M | -1.84M | -265k | -136k | -1.03B |
Financing | -1.19M | 18.55M | -4.55M | -237.55M | 277.16M |
Market Cap | 1.08B |
Price to Earnings Ratio | -1.05 |
Price to Sales Ratio | 2.38 |
Price to Cash Ratio | 11.45 |
Price to Book Ratio | -3.05 |
Dividend Yield | - |
Shares Outstanding | 156.53M |
Average Volume (1 week) | 2.06M |
Average Volume (1 Month) | 2.56M |
52 Week Change | -34.72% |
52 Week High | 15.70 |
52 Week Low | 6.21 |
Spread (Intraday) | 0.14 (2.03%) |
Company Name | Ironwood Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.ironwoodpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.